Department of Dermatology, University Hospital of Lille, Hôpital Claude-Huriez, Lille, France.
Dermatology. 2012;225(1):81-7. doi: 10.1159/000341523. Epub 2012 Sep 10.
Few data are available concerning the efficiency of pulse corticosteroids in alopecia areata (AA).
Our purpose was to assess the long-term outcomes of patients treated with methylprednisolone bolus.
This study included 60 patients treated between 1995 and 2000. The short-term outcomes were analyzed in 2000. The long-term assessment of 30 patients was performed in 2010 by phone questionnaire.
Significant hair regrowth was observed in 10/30 patients at 6 months after the bolus treatment. Half of the plurifocalis AA patients were responders at 6 months, but less than one quarter of alopecia totalis (AT) and alopecia universalis (AU) patients responded. Long-term outcomes were assessed after a mean duration of 12.3 years; 8/10 initial responders had mild or no disease, and 14/20 initial nonresponders had severe AA.
This study confirmed the low efficiency, both short- and long-term, of this treatment for AT and AU.
有关脉冲皮质类固醇治疗斑秃(AA)的疗效数据很少。
我们旨在评估甲泼尼龙冲击治疗的长期疗效。
本研究纳入了 1995 年至 2000 年间接受治疗的 60 例患者。2000 年对短期疗效进行了分析。2010 年通过电话问卷调查对 30 例患者进行了长期评估。
冲击治疗后 6 个月,10/30 例患者的毛发明显再生。脉冲皮质类固醇治疗 6 个月后,50%的多灶性 AA 患者有应答,但不到四分之一的全秃(AT)和普秃(AU)患者有应答。平均 12.3 年后进行长期疗效评估;10 例初始应答者中有 8 例病情轻微或无,20 例初始无应答者中有 14 例病情严重。
本研究证实了脉冲皮质类固醇治疗 AT 和 AU 的短期和长期疗效均较低。